Effects of Vitamin D3 (Cholecalciferol) on Adriamycin-Induced Nephrotoxicity

被引:11
|
作者
Dabak, Durrin Ozlem [1 ,2 ]
Kuloglu, Tuncay [1 ,2 ]
Ozercan, Mehmet Resat [3 ]
机构
[1] Firat Univ, Sch Med, Dept Histol, TR-23119 Elazig, Turkey
[2] Firat Univ, Sch Med, Dept Embryol, TR-23119 Elazig, Turkey
[3] Firat Univ, Sch Med, Dept Pathol, TR-23119 Elazig, Turkey
关键词
adriamycin; nephrotoxicity; vitamin D; INDUCED NEPHROTIC SYNDROME; INJURY; CELLS; MODEL; MACROPHAGES; PROGRESSION; GLOMERULOSCLEROSIS; NEPHROPATHY; DEPLETION; SEQUENCE;
D O I
10.1080/08860220902883020
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Although immune-mediated pathogenesis in adriamycin (ADR)-induced nephropathy has been proposed recently, studies are lacking about the effects of immunmodulators, such as vitamin D, on ADR-induced nephrotoxicity. We hypothesized that vitamin D-3 (cholecalciferol) would be beneficial on ADR-induced nephropathy because of its immunmodulatory properties. Eighteen male Wistar rats were divided into three groups (n = 6): group 1 (control), group 2 (single ADR injection intravenously), and group 3 (similar single ADR injection intravenously + daily oral cholecalciferol for 21 days) were used in the study. A single high dose of ADR resulted in increased urinary protein: creatinine ratio for all three weeks of the experiment in both groups 2 and 3 compared with the controls. Histological examination of the kidney tissue revealed distinct tubular lesions as tubular necrosis, hyaline casts in tubular lumen, tubular degeneration, tubular dilatation, and tubular vacuolization in group 2 compared with group 1. These tubular lesions were significantly reduced in group 3 compared to group 2. The results of this study indicate that cholecalciferol causes satisfactory tubulointerstitial recovery in ADR-induced nephrotoxicity in rats.
引用
收藏
页码:400 / 405
页数:6
相关论文
共 50 条
  • [21] Effects of supraphysiological vitamin D3 (cholecalciferol) supplement on normal adult rat ovarian functions
    Bassem Refaat
    Mohamed El-Boshy
    Histochemistry and Cell Biology, 2021, 155 : 655 - 668
  • [22] Production and characterization of polyclonal antibodies against cholecalciferol (vitamin D3)
    Jean, J
    Turcotte, C
    Simard, RE
    Fliss, I
    JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 223 (02) : 155 - 163
  • [23] RELATIONSHIP OF SERUM CHOLECALCIFEROL (VITAMIN D3) LEVEL WITH MUSCULOSKELETAL SYMPTOMS
    Razzaque, M. A.
    Dewan, G.
    Biswas, R. S.
    Karim, M. N.
    Sultan, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1647 - 1648
  • [24] Review: Cholecalciferol (vitamin D3) reduces mortality in adults; other forms of vitamin D do not
    Murff, Harvey J.
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (10)
  • [25] Cholecalciferol (D3) versus Ergocalciferol (D2): Which Vitamin D to Use?
    Nguyen, Timothy
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2017, 13 (06): : 442 - 443
  • [26] Pea Protein Nanoemulsion and Nanocomplex as Carriers for Protection of Cholecalciferol (Vitamin D3)
    Jiang, Shanshan
    Yildiz, Gulcin
    Ding, Junzhou
    Andrade, Juan
    Rababahb, Taha M.
    Almajwalc, Ali
    Abulmeatyc, Mahmoud M.
    Feng, Hao
    FOOD AND BIOPROCESS TECHNOLOGY, 2019, 12 (06) : 1031 - 1040
  • [27] Cholecalciferol (Vitamin D3) Improves Myelination and Recovery after Nerve Injury
    Chabas, Jean-Francois
    Stephan, Delphine
    Marqueste, Tanguy
    Garcia, Stephane
    Lavaut, Marie-Noelle
    Catherine Nguyen
    Legre, Regis
    Khrestchatisky, Michel
    Decherchi, Patrick
    Feron, Francois
    PLOS ONE, 2013, 8 (05):
  • [28] Pea Protein Nanoemulsion and Nanocomplex as Carriers for Protection of Cholecalciferol (Vitamin D3)
    Shanshan Jiang
    Gulcin Yildiz
    Junzhou Ding
    Juan Andrade
    Taha M. Rababahb
    Ali Almajwalc
    Mahmoud M. Abulmeatyc
    Hao Feng
    Food and Bioprocess Technology, 2019, 12 : 1031 - 1040
  • [29] PROTECTIVE EFFECTS OF PROBUCOL IN ADRIAMYCIN-INDUCED CARDIOMYOPATHY
    SIVESKIILISKOVIC, N
    KAUL, N
    THOMAS, TP
    SINGAL, PK
    FASEB JOURNAL, 1993, 7 (03): : A194 - A194
  • [30] Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
    Mansouri, Esrafil
    Assarehzadegan, Mohammad-Ali
    Nejad-Dehbashi, Fereshteh
    Kooti, Wesam
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2018, 17 (04): : 1413 - 1419